Serina Therapeutics (SER) Enterprise Value (2017 - 2026)
Serina Therapeutics (SER) posted Enterprise Value of -$3.1 million for Q4 2025, up 65.22% sequentially from -$8.8 million in Q3 2025, and up 19.68% YoY from -$2.6 million in Q4 2024.
Serina Therapeutics (SER) Enterprise Value (2017 - 2026) Analysis & Trends
Serina Therapeutics has reported Enterprise Value for 9 years, with the latest figure at -$3.1 million in Q4 2025.
- Quarterly Enterprise Value rose 19.68% year-over-year to -$3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.1 million (up 19.68% YoY) and the FY2025 annual result came in at -$3.1 million, up 19.68% from the prior year.
- Enterprise Value advanced to -$3.1 million in Q4 2025 per SER's latest filing, from -$8.8 million in the prior quarter.
- Over five years, Enterprise Value peaked at $28.8 million in Q4 2023 and troughed at -$8.8 million in Q3 2025.
- A 5-year average of -$1.1 million and a median of -$785500.0 in 2021 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value soared 3948.26% in 2023, then tumbled 2126.6% in 2024.
- Over 5 years, Enterprise Value stood at -$627000.0 in 2021, then fell by 19.3% to -$748000.0 in 2022, then jumped by 3948.26% to $28.8 million in 2023, then slumped by 113.22% to -$3.8 million in 2024, then gained by 19.68% to -$3.1 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$3.1 million, -$8.8 million, and -$6.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 2.12 Bn |
| 10 | Serina Therapeutics | 43.42 Mn | 20.40 Mn | - | -23.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.02 Mn |
| Dec 31, 2025 | -3.06 Mn |
| Sep 30, 2025 | -8.79 Mn |
| Jun 30, 2025 | -6.16 Mn |
| Mar 31, 2025 | -4.44 Mn |
| Dec 31, 2024 | -3.81 Mn |
| Sep 30, 2024 | -3.24 Mn |
| Jun 30, 2024 | -6.09 Mn |
| Mar 31, 2024 | -8.71 Mn |
| Dec 31, 2023 | 28.79 Mn |
| Sep 30, 2023 | -506,000.00 |
| Jun 30, 2023 | -382,000.00 |
| Mar 31, 2023 | -391,000.00 |
| Dec 31, 2022 | -748,000.00 |
| Sep 30, 2022 | -511,000.00 |
| Jun 30, 2022 | -744,000.00 |
| Mar 31, 2022 | -444,000.00 |
| Dec 31, 2021 | -627,000.00 |
| Sep 30, 2021 | -823,000.00 |
| Jun 30, 2021 | -707,000.00 |